Vascular Pathways, a privately held medical device manufacturer with a product for peripheral intravenous access, has elected Eugene Starr as president, chief executive officer and member of its board of directors.
The new appointment follows the company’s recent $14m Series B financing by venture capital firms CHL Medical Partners, Ascension Health Ventures, MVM Life Science Partners and Arcus Ventures.
Vascular Pathways has also reported that it will relocate its headquarters to Naples.
Vascular Pathways said that Starr has an experience as a senior executive in the medical device industry, compiling a successful track record in growing young companies and corporate operating divisions.
Vascular Pathway interim chief executive officer Nelson Stacks said that Starr has the right experience, market insights and proven leadership to build Vascular Pathways into a highly successful global medical device company, and they are excited to have attracted a CEO of his caliber.
“We look forward to working with Gene to make the Rapid IntraVascular Start (RIVS) IV catheter the new standard in peripheral intravenous access, bringing benefits to clinicians and patients across the United States and internationally,” Stacks said.